- Prevalence of Extended-Spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from Daejeon
-
Ko CS, Sung JY, Koo SH, Kwon GC, Shin SY, Park JW
- KMID: 1781533
- Korean J Lab Med.
- 2007 Oct;27(5):344-350.
- doi: 10.3343/kjlm.2007.27.5.344
BACKGROUND: Extended-spectrum beta-lactamases (ESBLs) are cephalosporinases that confer resistance to a wide variety of oxyimino cephalosporins and create serious therapeutic problems. Although ESBLs have been reported with increasing frequency... -
- CITED
-
- Close
- SHARE
-
- Close
- Amikacin therapy for urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli
-
Cho SY, Choi SM, Park SH, Lee DG, Choi JH, Yoo JH
- KMID: 2373784
- Korean J Intern Med.
- 2016 Jan;31(1):156-161.
- doi: 10.3904/kjim.2016.31.1.156
BACKGROUND/AIMS: The number of urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) is increasing. In an outpatient setting, there are limited therapeutic options to treat ESBL-producing pathogens.... -
- CITED
-
- Close
- SHARE
-
- Close
- Antibiotic Resistance Mechanisms of Escherichia coli Isolates from Urinary Specimens
-
Song S, Lee EY, Koh EM, Ha HS, Jeong HJ, Bae IK, Jeong SH
- KMID: 1781589
- Korean J Lab Med.
- 2009 Feb;29(1):17-24.
- doi: 10.3343/kjlm.2009.29.1.17
BACKGROUND: This study was designed to characterize urinary isolates of Escherichia coli that produce extended-spectrum beta-lactamases (ESBLs) and to determine the prevalence of other antimicrobial resistance genes. METHODS: A total... -
- CITED
-
- Close
- SHARE
-
- Close
